Trends in Psychiatry and Psychotherapy
https://trends.org.br/article/doi/10.1590/2237-6089-2016-0004
Trends in Psychiatry and Psychotherapy
Original Article

Screening for symptoms of anxiety and depression in patients admitted to a university hospital with acute coronary syndrome

Rastreio de sintomas ansiosos e depressivos em pacientes com síndrome coronariana aguda internados em um hospital universitário

Carolina Casanova Meneghetti; Bruno Luiz Guidolin; Paulo Roberto Zimmermann; Ana Sfoggia

Downloads: 0
Views: 323

Abstract

Abstract Objective: To investigate the prevalence of anxiety and depression in patients admitted for acute coronary syndrome to a university hospital and to examine associations with use of psychotropic drugs. Methods: Ninety-one patients who had had an acute coronary event were enrolled on this cross-sectional prevalence study. Characteristics of the study population and the prevalence rates of depression and anxiety in the sample were assessed using the Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) psychiatric consultation protocol, which includes clinical and sociodemographic data, and the Hospital Anxiety and Depression Scale (HADS). Results: The prevalence of symptoms of anxiety was 48.4% (44 patients) and the prevalence of depressive symptoms was 26.4% (24 patients). Of these, 19 patients (20.9% of the whole sample) had scores indicative of both types of symptoms concomitantly. Considering the whole sample, just 17 patients (18.7%) were receiving treatment for anxiety or depression with benzodiazepines and/or antidepressants. Conclusions: Anxiety and depression are disorders that are more prevalent among patients with acute coronary syndrome than in the general population, but they are generally under-diagnosed and under-treated. Patients with anxiety and depression simultaneously had higher scores on the HADS for anxiety and depression and therefore require more intensive care.

Keywords

Anxiety, depression, HADS, acute coronary syndrome, psychopharmaceuticals

Resumo

Resumo Objetivo: Investigar a prevalência de ansiedade e depressão em pacientes com síndrome coronariana aguda internados em um hospital universitário e examinar sua associação com o uso de drogas psicotrópicas. Métodos: Noventa e um pacientes que sofreram evento coronariano agudo foram incluídos nesse estudo transversal de prevalência. O protocolo de interconsulta psiquiátrica do Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), com os dados clínicos e sociodemográficos, e a Escala Hospitalar de Ansiedade e Depressão (HADS) foram utilizados para avaliar as características da população estudada e a prevalência de depressão e ansiedade nessa amostra. Resultados: A prevalência de sintomas ansiosos foi de 48,4% (44 pacientes), e a de sintomas depressivos, de 26,4% (24 pacientes). Desses, 19 (20,9% do total da amostra) pontuaram para os dois sintomas concomitantemente. Considerando a amostra como um todo, apenas 17 pacientes (18,7%) estavam recebendo tratamento para ansiedade ou depressão com benzodiazepínicos e/ou antidepressivos. Conclusão: Ansiedade e depressão são transtornos mais prevalentes em pacientes com síndrome coronariana aguda do que na população geral, mas geralmente são subdiagnosticados e subtratados. Os pacientes com presença simultânea de ansiedade e depressão apresentam escores mais altos na escala HADS para ansiedade e depressão e necessitam, portanto, de um controle mais intensivo.

Palavras-chave

Ansiedade, depressão, HADS, síndrome coronariana aguda, psicofármacos

References

Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. 2011.

Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007;370:1089-100.

Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA. INTERHEART Investigators Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:953-62.

Cohen BE, Edmondson D, Kronish IM. State of the art review depression, stress anxiety, and cardiovascular disease. Am J Hypertens. 2015;28:1295-302.

Lichtman JH, Bigger Jr JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F. Depression and coronary heart disease recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768-75.

Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129:1350-69.

Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease a meta-analysis. J Am Coll Cardiol. 2010;56:38-46.

Meyer T, Hussein S, Lange HW, Herrmann-Lingen C. Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. Eur J Prev Cardiol. 2015;22:75-82.

Morys JM, Bellwon J, Adamczyk K, Gruchala M. Depression and anxiety in patients with coronary artery disease measured by means of self-report measures and clinican-rated instrument. Kardiol Pol. 2016;74:53-60.

Lawton R, Seed PT, Kordowicz M, Schofield P, Tylee A, Ashworth M. Using a patient-generated mental-health measure "PSYCHLOPS" to explore problems in patients with coronary heart disease. Br J Gen Pract. 2014;64:e354-63.

Lane D, Carroll D, Ring C, Beevers DG, Lip GY. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol. 2002;7:11-21.

Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life the Heart and Soul Study. JAMA. 2003;290:215-21.

Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527-37.

Ceccarini M, Manzoni GM, Castelnuevo G. Assessing depression in cardiac patients what measures should be considered?. Depress Res Treat. 2014;2014:148256.

Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, Fricchione GL. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol. 2006;98:319-24.

Roest AM, Zuidersma M, de Jonge P. Myocardial infarction and generalised anxiety disorder 10-year follow-up. Br J Psychiatry. 2012;200:324-9.

Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2- year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65:62-71.

Parker GB, Owen CA, Brotchie HL, Hyett MP. The impact of differing anxiety disorders on outcome following an acute coronary syndrome time to start worrying?. Depress Anxiety. 2010;27:302-9.

Tully PJ, Penninx BW. Depression and anxiety among coronary heart disease patients can affect dimensions and theory inform diagnostic disorder-based screening?. J Clin Psychol. 2012;68:448-61.

Carinci F, Nicolucci A, Ciampi A, Labbrozzi D, Bettinardi O, Zotti AM. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction Application of recursive partitioning techniques to the GISSI-2 database. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Eur Heart J. 1997;18:835-45.

Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG. Gender, depression and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26-37.

Benninghoven D, Kaduk A, Wiegand U, Specht T, Kunzendorf S, Jantschek G. Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function. Psychother Psychosom. 2006;75:56-61.

Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998;155:4-11.

Rugulies R. Depression as a predictor for coronary heart disease a review and meta-analysis. Am J Prev Med. 2002;23:51-61.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.

Kaur S, Zainal NZ, Low WY, Ramasamy R, Sidhu JS. Factor Structure of Hospital Anxiety and Depression Scale in Malaysian patients with coronary artery disease. Asia Pac J Public Health. 2015;27:450-60.

Hunt-Shanks T, Blanchard C, Reid R, Fortier M, Cappelli M. A psychometric evaluation of the Hospital Anxiety and Depression Scale in cardiac patients addressing factor structure and gender invariance. Br J Health Psychol. 2010;15:97-114.

Bambauer KZ, Locke SE, Aupont O, Mullan MG, McLaughlin TJ. Using the Hospital Anxiety and Depression Scale to screen for depression in cardiac patients. Gen Hosp Psychiatry. 2005;27:275-84.

Doyle F, Conroy R, McGee H, Delaney M. Depressive symptoms in persons with acute coronary syndrome specific symptom scales and prognosis. J Psychosom Res. 2010;68:121-30.

Martin CR, Lewin RJP, Thompson DR. A confirmatory factor analysis of the Hospital Anxiety and Depression Scale in coronary care patients following acute myocardial infarction. Psychiatry Res. 2003;120:85-94.

Botega NJ, Bio MR, Zomignani MA, Garcia Jr C, Pereira WA. Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saude Publica. 1995;29:355-63.

Frasure-Smith N, Lespérance F, Gravel G, Masson A, Juneau M, Talajic M. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919-24.

Burg MM, Meadows J, Shimbo D, Davidson KW, Schwartz JE, Soufer R. Confluence of depression and acute psychological stress among patients with stable coronary heart disease: effects on myocardial perfusion. J Am Heart Assoc. 2014;30(3):e000898.

Pinton FA, Carvalho CF, Miayazaki MCOS, Godoy MF. Depressão como fator de risco de morbidade imediata e tardia pós-revascularização cirúrgica do miocárdio. Rev Bras Cir Cardiovasc. 2006;21:68-74.

Watkins LL, Koch GG, Sherwood A, Blumenthal JA, Davidson JR, O´Connor C. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc. 2013;2:000068.

Pajak A, Jankowski P, Kotseva K, Heidrich J, de Smedt D, De Bacquer D. EUROASPIRE Study Group Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol. 2013;20:331-40.

Doering LV, Moser DK, Riegel B, McKinley S, Davidson P, Baker H. Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease. Int J Cardiol. 2010;145:188-92.

Walters P, Barley EA, Mann A, Phillips R, Tylee A. Depression in primary care patients with heart disease baseline findings from the UPBEAT UK study. PLoS One. 2014;9:e98342.

Beekman AT, de Beurs E, Van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. Anxiety and depression in later life co occurrence and communality of risk factors. Am J Psychiatry. 2000;157:89-95.

Zajecka JM, Ross JS. Management of comorbid anxiety and depression. J Clin Psychiatry. 1995;56:10-3.

Ghaemi SN. Why antidepressants are not antidepressants STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord. 2008;10:957-68.

Phillips AC, Batty GD, Gale CR, Deary IJ, Osborn D, MacIntyre K. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality the Vietnam experience study. Psychosom Med. 2009;71:395-403.

Mattos MA, Lougon M, Tura BR, Pereira BB. Depressão e síndrome isquêmica coronariana aguda. Rev SOCERJ. 2005;18:288-94.

Gerber Y, Weston SA, Killian JM, Jacobsen SJ, Roger VL. Sex and classic risk factors after myocardial infarction a community study. Am Heart J. 2006;152:461-8.

Leifheit-Limson EC, D'Onofrio G, Daneshvar M, Geda M, Bueno H, Spertus JA. Sex differences in cardiac risk factors, perceived risk, and health care provider discussion of risk and risk modification among young patients with acute myocardial infarction the VIRGO study. J Am Coll Cardiol. 2015;66:1949-57.

Gulliksson M, Burell G, Lundin L, Toss H, Svärdsudd K. Psychosocial factors during the first year after a coronary heart disease event in cases and referents Secondary Prevention in Uppsala Primary Health Care Project (SUPRIM). BMC Cardiovasc Disord. 2007;7:36.

Rohyans LM, Pressler SJ. Depressive symptoms and heart failure examining the sociodemographic variable. Clin Nurse Spec. 2009;23:138-44.

Luttik ML, Jaarsma T, Veeger N, van Veldhuisen DJ. Marital status, quality of life, and clinical outcome in patients with heart failure. Heart Lung. 2006;35:3-8.

6169cb5da9539553513b4d85 trends Articles
Links & Downloads

Trends Psychiatry Psychother

Share this page
Page Sections